Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Jun 2025 for Adicet Bio, Inc.. Read the official filing
Filing timeline
BuySaleSteve Dubin
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Steve Dubin: trading record in brief
Steve Dubin discloses dealings in Adicet Bio, Inc. to SEC (Form 4). Between 1 June 2023 and 11 June 2025, the trades on record add up to 4 filings.
The open-market record is one-sided, with 1 purchase worth €11k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants.
The latest filing, published on 13 June 2025, reports a share grant in Adicet Bio, Inc. The last purchase on record was published on 30 June 2023, which is 1,206 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Steve Dubin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
5,900 shares0Common StockSEC:0000950170-25-086160:0
5,900 shares0Common StockSEC:0000950170-24-070608:0
5,000 shares@ US$2.3999100.0% of flowCommon StockSEC:0001209191-23-040299:0
Canonical exit: 28 Sept 2023 (T+90)
5,900 shares0Common StockSEC:0001209191-23-033956:0
4 of 4 declarations
